Diabetes: Does aspirin use reduce cardiovascular risk in diabetes?

Nature Reviews Endocrinology

Volumn 5, Issue 4, 2009, Pages 188-190

  Colwell, John A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; OMEGA 3 FATTY ACID; SIMVASTATIN; ANTITHROMBOCYTIC AGENT;

AGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG USE; HUMAN; JAPANESE; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; SHORT SURVEY; ATHEROSCLEROSIS; NOTE;

ASPIRIN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 67649362165     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.44     Document Type: Short Survey

References (10)

1. Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K. & Laakso, M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339, 229-234 (1998).
2. Patrono, C., Garcia Rodriguez, L. A., Landolfi, R. & Baigent, C. Low-dose aspirin for the prevention of atherothrombosis. N. Engl. J. Med. 353, 2373-2383 (2005).
3. Ogawa, H. et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 300, 2134-2141 (2008).
4. Sacco, M. et al. Primary prevention of cardiovascular events with low-dose aspirin and vitamin e in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26, 3264-3272 (2003).
5. [no authors listed] Aspirin effects on mortality and morbidity in patients with diabetes mellitus. eTDRs investigators. JAMA 268, 1292-1300 (1992).
6. Hansson, L. et al. effects of intensive bloodpressure- lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT study. Lancet 351, 1755-1762 (1998). (Pubitemid 28269185)
7. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324, 71-86 (2002).
8. American Diabetes Association. standards of medical care in diabetes-2007. Diabetes Care 30 (suppl.1), s4-s41 (2007).
9. A study of Cardiovascular events in Diabetes. [http://www.ctsu.ox.ac.uk/ ascend/ about-pro.htm] (accessed February 9, 2009).
10. De Berardis, G. et al. Aspirin and simvastatin combination for cardiovascular events prevention trial in diabetes (ACCePT-D): design of a randomized study of the efficacy of lowdose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 8, 21-29 (2007).